NCPDP and SAFE-BioPharma to Collaborate on Life Science Standards

SCOTTSDALE, Ariz. & FORT LEE, N.J.--(BUSINESS WIRE)-- The National Council for Prescription Drug Programs (NCPDP) and SAFE-BioPharma Association announced today a strategic alliance to advance use of their respective standards within the life sciences.

NCPDP is an ANSI-accredited standards development organization which has led transformation in the pharmacy services sector by creating and promoting standards for electronic healthcare transactions. Working closely with its 1,600+ members, NCPDP has produced operational efficiencies that save more than $30 billion annually in healthcare costs, while increasing the safety and quality of patient care. NCPDP standards, such as the Telecommunication Standard for billing and reporting claims and services, and the SCRIPT Standard for electronic prescribing, have been named in federal legislation, including HIPAA, MMA and HITECH.

SAFE-BioPharma Association created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. The SAFE-BioPharma standard provides a secure, legally enforceable and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. The standard is compliant with HIPAA regulations, and is recognized by the Drug Enforcement Agency (DEA) as compliant with its rules for ePrescribing of controlled substances.

The two organizations will collaborate in meetings, working groups and a variety of other forums.

“We are dedicated to transforming the healthcare system by collaborating on business solutions. Collaborating with SAFE-BioPharma will benefit the advancement of standardized solutions throughout the pharmacy services industry,” said Lee Ann Stember, president, NCPDP. NCPDP members represent every segment of the pharmacy services sector, as well as other healthcare stakeholder groups.

SAFE-BioPharma facilitates interoperability and integration among researchers, vendors, regulators, clinicians, prescribers, healthcare providers, and other pharmaceutical and healthcare stakeholders. SAFE-BioPharma digital signatures are widely accepted by global regulatory agencies.

“Our collaboration with NCPDP will lead to even greater process and cost improvements for healthcare and other sectors of the life sciences. The SAFE-BioPharma standard helps assure the secure transmission of confidential and regulated health-related information. We believe that both of our organizations will benefit,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. The association’s members include Abbott, Amgen, AstraZeneca, Forest Laboratories, GlaxoSmithKline, Johnson & Johnson, Lilly, Merck, Pfizer, Roche and sanofi-aventis.

About NCPDP

Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with over 1,600 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for e-Prescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data services include the NCPDP Provider Identification Number, a unique identifier of over 75,000 pharmacies, and HCIdea, “The Prescriber Identity Solution.” For more information about NCPDP Standards, Data Services, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call (480) 477-1000.

About SAFE-BioPharma

SAFE-BioPharma is the global industry standard for digital trust. It was developed by a non-profit consortium of biopharmaceutical and related companies to transition the biopharmaceutical and health care communities to paperless environments. For more information visit: http://www.safe-biopharma.org

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association



CONTACT:

SAFE-BioPharma Association
Jon Weisberg, 801-860-9977
[email protected]
or
Amendola Communications for NCPDP
Janet Cabibbo, 480-664-8412 ext. 15
[email protected]

KEYWORDS:   United States  North America  Arizona  New Jersey

INDUSTRY KEYWORDS:   Technology  Data Management  Electronic Design Automation  Internet  Networks  Software  Health  Biotechnology  Pharmaceutical  General Health

MEDIA:

Suggested Articles

An assessment looking at 12 health systems that allow patients to download their health records to their smartphones via APIs finds modest uptake.

The National Institutes of Health-led All of Us precision medicine health research database project has enrolled 230,000 participants.

Hospitals must pursue a deliberate strategy for managing their public image—and a powerful tool for doing so is inpatient clinical data registries.